Market opportunity Target the expanding veterinary hospital-at-home segment driven by a $12B+ market, focusing on clinics looking to increase throughput and reduce ICU occupancy with infusion-to-go capabilities.

Unique value Highlight the Mini-Infuser as a non-electronic, wearables-based infusion solution that minimizes risk of electronic failure, battery dependency, and software complexity while delivering hospital-grade precision.

Expansion potential Position for growth through Journey Legacy Partners acquisition to scale a non-powered, 48-hour wearable infusion system across multispecies home recovery, enabling rapid scaling and broader adoption.

Operational savings Emphasize clinic workflow benefits such as freeing up ICU space, improving patient throughput, and enabling stable patients to transition to outpatient care without compromising care quality.

Go-to-market fit Leverage the current small team size to partner with distributors or veterinary chains, leveraging scalable manufacturing and a streamlined deployment model to accelerate global adoption.